Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women
- PMID: 24201689
- DOI: 10.1097/AOG.0000000000000010
Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women
Abstract
Objective: To characterize maternal and infant outcomes for pregnant women who received live H1N1 influenza vaccine and had no reported adverse events.
Methods: We identified Vaccine Adverse Event Reporting System reports, which described receipt of live H1N1 vaccine during pregnancy without an indication of an adverse event at the time of the report during October 2009 to June 2010. We reviewed the initial reports and obtained pregnancy outcome and infant data through 6 months of age from medical records. We reviewed the numbers and characteristics of pregnancy complications and infant outcomes including major birth defects and medically important infant conditions. Rates of spontaneous abortion, preterm birth, and major birth defects and their 95% confidence intervals were calculated.
Results: The Vaccine Adverse Event Reporting System received 113 reports stating receipt of live H1N1 vaccine during pregnancy with no adverse events reported. We obtained follow-up maternal records on 95 of the 113 (84%) live H1N1 reports (40.2% were vaccinated in the first trimester) and found: 87 live births (two twin pregnancies) and no maternal deaths occurred. Number and rates of pregnancy-specific adverse events included: 10 (10.5%, 5.8-18.3) spontaneous abortions; four (4.7%, 1.8-11.4) preterm deliveries at 35-36 weeks of gestation; three (3.4%, 1.2-9.7) infants had one or more major birth defects noted at birth: one cleft palate, one cleft lip, and one microtia (underdeveloped or absent external ear). Seven neonates and infants were hospitalized for medically important conditions. One infant death occurred in a 2.5-month-old boy as a result of pertussis.
Conclusion: Rates of spontaneous abortion, preterm birth, and major birth defects in pregnant women who received live H1N1 vaccine were similar to or lower than published background rates. No concerning patterns of medical conditions in infants were identified.
Level of evidence: : III.
Comment in
-
Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women.Obstet Gynecol. 2014 Mar;123(3):665-666. doi: 10.1097/AOG.0000000000000153. Obstet Gynecol. 2014. PMID: 24553156 No abstract available.
-
In reply.Obstet Gynecol. 2014 Mar;123(3):666. doi: 10.1097/AOG.0000000000000154. Obstet Gynecol. 2014. PMID: 24553157 No abstract available.
Similar articles
-
A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.Vaccine. 2018 May 11;36(20):2855-2860. doi: 10.1016/j.vaccine.2018.03.061. Epub 2018 Apr 3. Vaccine. 2018. PMID: 29625766
-
Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.Vaccine. 2015 Apr 27;33(18):2108-17. doi: 10.1016/j.vaccine.2015.02.068. Epub 2015 Mar 8. Vaccine. 2015. PMID: 25758932 Review.
-
Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.Vaccine. 2014 Nov 12;32(48):6463-8. doi: 10.1016/j.vaccine.2014.09.054. Epub 2014 Oct 5. Vaccine. 2014. PMID: 25285884
-
Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.Vaccine. 2013 Oct 17;31(44):5026-32. doi: 10.1016/j.vaccine.2013.08.097. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24016809
-
Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.Expert Rev Vaccines. 2012 Aug;11(8):911-21. doi: 10.1586/erv.12.72. Expert Rev Vaccines. 2012. PMID: 23002972 Review.
Cited by
-
Comprehensive Overview of Vaccination during Pregnancy in Europe.J Pers Med. 2021 Nov 13;11(11):1196. doi: 10.3390/jpm11111196. J Pers Med. 2021. PMID: 34834548 Free PMC article. Review.
-
Determinants of orofacial clefting II: Effects of 5-Aza-2'-deoxycytidine on gene methylation during development of the first branchial arch.Reprod Toxicol. 2017 Jan;67:100-110. doi: 10.1016/j.reprotox.2016.11.020. Epub 2016 Dec 5. Reprod Toxicol. 2017. PMID: 27923600 Free PMC article.
-
Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies.Am J Epidemiol. 2016 Aug 1;184(3):176-86. doi: 10.1093/aje/kww043. Epub 2016 Jul 22. Am J Epidemiol. 2016. PMID: 27449414 Free PMC article.
-
A systematic review of ethical issues in vaccine studies involving pregnant women.Hum Vaccin Immunother. 2016 Aug 2;12(8):1952-1959. doi: 10.1080/21645515.2016.1186312. Epub 2016 May 31. Hum Vaccin Immunother. 2016. PMID: 27246403 Free PMC article. Review.
-
Maternal vaccination for the prevention of influenza: current status and hopes for the future.Expert Rev Vaccines. 2016 Oct;15(10):1255-80. doi: 10.1080/14760584.2016.1175304. Epub 2016 Apr 22. Expert Rev Vaccines. 2016. PMID: 27070268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials